Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function

Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)

(2009) H. Kasanuki et al.   EUROPEAN HEART JOURNAL

The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease

(2009) Fadi G. Hage et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin receptor blockers: RAAS blockade and renoprotection

(2008) Luis M. Ruilope   CURRENT MEDICAL RESEARCH AND OPINION

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks

(2008) Toshio Ogihara et al.   HYPERTENSION

Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice

(2008) Vivencio Barrios et al.   JOURNAL OF HYPERTENSION

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE